Get a reply from this recruiter
Your resume and cover letter, tailored to exactly what they’re hiring for.
Meet Life Sciences Ltd. in Hannover is seeking a Territory Account Manager to drive engagement across Hannover, Braunschweig, Magdeburg and nearby markets.
You will map treatment centres, strengthen relations with healthcare teams, and align commercial priorities with medical affairs colleagues in a field-based role. The successful candidate will have 3+ years in biopharma field sales, strong account management, and willingness to travel, including nights away.
Hannover, Braunschweig & Magdeburg | Germany | Field-based
Success across Hannover, Braunschweig and Magdeburg will not come from treating every customer alike. It needs someone who can spot the most important treatment centres, recognise different account needs and build a credible plan around them.
Meet is supporting argenx as it expands its German team, with a Territory Account Manager opportunity in central northern Germany.
You will be trusted to understand the territory in detail: map diagnosis and treatment centres, strengthen relationships with healthcare teams and keep commercial priorities moving. Medical Affairs and strategic-account colleagues will be key partners, while delivery against territory objectives remains your responsibility.
Hannover, Braunschweig, Wolfsburg, Hildesheim and Magdeburg.
Celle, Salzgitter, Wolfenbüttel, Peine and Goslar.
At argenx, we build our culture from the collective power of the team and the knowledge that together, we are better. If you are entrepreneurial, curious and committed to make a difference for patients and thrive on creating solutions for rare autoimmune diseases, then argenx is for you.
Next to a competitive salary with extensive benefits, we offer you the chance to grow and be a part of a team driven by purpose, creativity, innovation and science.
argenx is a fast-growing global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Thanks to colleagues based in Europe, the United States and Japan, we translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.